TS Financial Group (TSFG)’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Hold |
1,058
| – | – | ﹤0.01% | 649 |
|
|
2025
Q1 | $6K | Buy |
1,058
+350
| +49% | +$1.99K | ﹤0.01% | 602 |
|
|
2024
Q4 | $2K | Hold |
708
| – | – | ﹤0.01% | 680 |
|
|
2024
Q3 | $2K | Hold |
708
| – | – | ﹤0.01% | 708 |
|
|
2024
Q2 | $2K | Hold |
708
| – | – | ﹤0.01% | 697 |
|
|
2024
Q1 | $2K | Buy |
+708
| New | +$2K | ﹤0.01% | 692 |
|
|
2023
Q2 | – | Sell |
-5,488
| Closed | -$9K | – | 1072 |
|
|
2023
Q1 | $9K | Hold |
5,488
| – | – | ﹤0.01% | 554 |
|
|
2022
Q4 | $7K | Hold |
5,488
| – | – | ﹤0.01% | 597 |
|
|
2022
Q3 | $9K | Hold |
5,488
| – | – | ﹤0.01% | 543 |
|
|
2022
Q2 | $8K | Buy |
+5,488
| New | +$8K | ﹤0.01% | 584 |
|
|
2022
Q1 | – | Sell |
-5,488
| Closed | -$16K | – | 1025 |
|
|
2021
Q4 | $16K | Buy |
+5,488
| New | +$16K | 0.01% | 478 |
|